Selected article for: "activator protein and acute respiratory syndrome sars cov coronavirus"

Author: Lin, Cheng-Wen; Lin, Kuan-Hsun; Hsieh, Tsung-Han; Shiu, Shi-Yi; Li, Jeng-Yi
Title: Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis
  • Cord-id: v6kw8xsh
  • Document date: 2006_4_1
  • ID: v6kw8xsh
    Snippet: The pathogenesis of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is an important issue for the treatment and prevention of severe acute respiratory syndrome. Recently, SARS-CoV has been demonstrated to induce cell apoptosis in Vero-E6 cells. The possible role of SARS-CoV 3C-like protease (3CL(pro)) in virus-induced apoptosis is characterized in this study. Growth arrest and apoptosis via caspase-3 and caspase-9 activities were demonstrated in SARS-CoV 3CL(pro)-expressing h
    Document: The pathogenesis of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is an important issue for the treatment and prevention of severe acute respiratory syndrome. Recently, SARS-CoV has been demonstrated to induce cell apoptosis in Vero-E6 cells. The possible role of SARS-CoV 3C-like protease (3CL(pro)) in virus-induced apoptosis is characterized in this study. Growth arrest and apoptosis via caspase-3 and caspase-9 activities were demonstrated in SARS-CoV 3CL(pro)-expressing human promonocyte cells. The fluorescence intensity of dihydrorhodamine 123 staining indicated that cellular reactive oxygen species were markedly increased in SARS-CoV 3CL(pro)-expressing cells. Moreover, in vivo signalling pathway assay indicated that 3CL(pro) increased the activation of the nuclear factor-kappa B-dependent reporter, but inhibited activator protein-1-dependent transcription. This finding is likely to be responsible for virus-induced apoptotic signalling.

    Search related documents:
    Co phrase search for related documents
    • active dimer form and acute respiratory syndrome: 1, 2
    • activity assay and acute phase: 1
    • activity assay and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity assay and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity assay and luciferase assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity assay and luciferase assay measure: 1, 2
    • activity assay and luciferase reporter: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • activity assay and lung tissue: 1, 2, 3
    • activity assay and lysis buffer: 1, 2, 3, 4
    • activity assay and madison wi: 1, 2
    • activity assay and madison wi promega: 1, 2
    • activity measure and acute phase: 1
    • activity measure and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • activity measure and luciferase activity: 1, 2, 3, 4
    • activity measure and luciferase assay: 1, 2, 3
    • activity measure and luciferase assay measure: 1, 2
    • activity measure and luciferase reporter: 1, 2, 3
    • activity profile and acute phase: 1
    • activity profile and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12